The Identification and Characterization of a New Carbapenem CS-023 Solvate Polymorph Achieved by the Appropriate Crystal Washing and Drying

References

• Altomare A, Burla MC, Camalli M, Cascarano GL, Giacovazzo C, Guagliardi A, Moliterni AGG, Polidori G, Spagna R. 1999. SIR 97: a new tool for crystal structure determination and refinement. J Appl Crystallogr. 32:115–119. doi: 10.1107/S0021889898007717
   Web of Science ®Google Scholar
• Barsky I, Bernstein J, Stephens PW, Stone KH, Cheung E, Hickey MB, Henck J-O. 2008. Disappearing and reappearing polymorphism in p-methylchalcone. Crystal Growth & Design. 8:63–70. doi: 10.1021/cg7007733
   Web of Science ®Google Scholar
• Braun DE, Kahlenberg V, Gelbrich T, Ludescher J, Griesser UJ. 2008. Solid state characterization of four solvates of R-cinacalcet hydrochloride. CrystEngComm. 10:1617–1625. doi: 10.1039/b809219b
   Web of Science ®Google Scholar
• Bučar D-KB, Lancaster RW, Bernstein J. 2015. Disappearing polymorphs revisited. Angew Chem Int Ed Engl. 54:6972–6993. doi: 10.1002/anie.201410356
   PubMed Web of Science ®Google Scholar
• Dance ZEX, Crawford M, Moment A, Brunskill A, Wabuyele B. 2020. Kinetics, thermodynamics, and scale-up of an azeotropic drying process: mapping rapid phase conversion with process analytical technology. Org Process Res Dev. 24:1665–1674. doi: 10.1021/acs.oprd.0c00275
   Web of Science ®Google Scholar
• Douillet J, Stevenson N, Lee M, Mallet F, Ward R, Aspin P, Dennehy DR, Camus L. 2012. Development of a solvate as an active pharmaceutical ingredient: developability, crystallisation and isolation challenges. J Cryst Growth. 342:2–8. doi: 10.1016/j.jcrysgro.2011.05.023
   Web of Science ®Google Scholar
• Dunitz DJ, Bernstein J. 1995. Disappearing polymorphs. Acc Chem Res. 28:193–200. doi: 10.1021/ar00052a005
   Web of Science ®Google Scholar
• Fujii K, Aoki M, Uekusa H. 2013. Solid-state hydration/dehydration of erythromycin a investigated by ab initio powder X-ray diffraction analysis: Stoichiometric and nonstoichiometric dehydrated hydrate. Crystal Growth & Design. 13:2060–2066. doi: 10.1021/cg400121u
   Web of Science ®Google Scholar
• Henck J-O, Bernstein J, Ellern A, Boese R. 2001. Disappearing and reappearing polymorphs, the benzocaine: picric acid system. J Am Chem Soc. 123:1834–1841. doi: 10.1021/ja002113o
   PubMed Web of Science ®Google Scholar
• Hsieh DS, Gao Q, Huang M, DiMemmo LM, Lindrud M, Razler T. 2017. From drying kinetics, solvate structure, particle morphology, and modeling to optimal drying protocol. Org Process Res Dev. 21:1509–1520. doi: 10.1021/acs.oprd.7b00162
   Web of Science ®Google Scholar
• Kalp M, Carey PR. 2008. Carbapenems and SHV-1 β-lactamase form different acyl-enzyme populations in crystals and solution. Biochemistry. 47:11830–11837. doi: 10.1021/bi800833u
   PubMed Web of Science ®Google Scholar
• Kawamoto I, Shimoji Y, Kanno O, Kojima K, Ishikawa K, Matsuyama E, Ashida Y, Shibayama T, Fukuoka T, Ohya S. 2003. Synthesis and structure-activity relationships of novel parenteral carbapenems, CS-023 (R-115685) and related compounds containing an amidine moiety. J Antibiot (Tokyo). 56:565–579. doi: 10.7164/antibiotics.56.565
   PubMed Web of Science ®Google Scholar
• Machiya K, Ieda S, Hirano M, Ooshima H. 2009. Effects of impurities on crystal polymorphism of an imidazopyridine derivative developed as a drug substance for osteoporosis. J Chem Eng Japan / JCEJ. 42:147–152. doi: 10.1252/jcej.08we259
   Web of Science ®Google Scholar
• Matsuura S, Igarashi K, Azuma M, Ooshima H. 2021. Polymorphic crystallization design to prevent the degradation of the β-lactam structure of a carbapenem. Crystals. 11:931–944. doi: 10.3390/cryst11080931
   Web of Science ®Google Scholar
• Mimura H, Kitamura S, Kitagawa T, Kohda S. 2002. Characterization of the non-stoichiometric and isomorphic hydration and solvation in FK041 clathrate. Colloids Surf, B. 26:397–406. doi: 10.1016/S0927-7765(02)00026-7
   Web of Science ®Google Scholar
• Morissette SL, Soukasene S, Levinson D, Cima MJ, Almarsson Ö. 2003. Elucidation of crystal form diversity of the HIV protease inhibitor ritonavir by high-throughput crystallization. Proc Natl Acad Sci USA. 100:2180–2184. doi: 10.1073/pnas.0437744100
   PubMed Web of Science ®Google Scholar
• Okamoto M, Hamano M, Igarashi K, Ooshima H. 2004. the effects of impurities on crystallization of polymorphs of a drug substance AE1-923. J Chem Eng Japan / JCEJ. 37:1224–1231. doi: 10.1252/jcej.37.1224
   Web of Science ®Google Scholar
• Sheldrick GM, Thomas RS. 1997. [16] SHELXL: High-resolution refinement. Methods Enzymol. 277:319–343. doi: 10.1016/S0076-6879(97)77018-6
   PubMed Web of Science ®Google Scholar
• Shibayama T, Sugiyama D, Kamiyama E, Tokui T, Hirota T, Ikeda T. 2007. Characterization of CS-023 (RO4908463), a novel parenteral carbapenem antibiotic, and meropenem as substrates. Drug Metab Pharmacokinet. 22:41–47. doi: 10.2133/dmpk.22.41
   PubMed Web of Science ®Google Scholar